Renal Replacement Therapy clinical trials at UCSF
1 in progress, 0 open to new patients
Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
Sorry, in progress, not accepting new patients
This is a 2-year, randomized, multicenter, open-label, 2-arm study evaluating the graft function of everolimus and reduced CNI versus MPA and standard CNI in adult de novo renal transplant recipients.
San Francisco, California and other locations